Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
130 hedge funds and large institutions have $973M invested in Flexion Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 39 reducing their positions, and 20 closing their positions.
189% more call options, than puts
Call options by funds: $11.9M | Put options by funds: $4.12M
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
18% more capital invested
Capital invested by funds: $823M → $973M (+$150M)
18% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 39
3% less funds holding
Funds holding: 134 → 130 (-4)
20% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$14.1M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$6.4M |
| 3 |
ZDA
Zweig-DiMenna Associates
New York
|
+$5.79M |
| 4 |
BlackRock
New York
|
+$5.64M |
| 5 |
CC
Clearline Capital
New York
|
+$5.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$18M |
| 2 |
State Street
Boston,
Massachusetts
|
-$7.44M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$6.45M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.08M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.24M |
FLXN Hedge Fund Activity: Q2 2018 in Review
130 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q2 2018, worth a combined $973M — up 18% from $823M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of FLXN and 16 opened new positions — a net loss of 4 holders — while 39 trimmed existing stakes and 46 added.
The largest buyer was Artisan Partners, opening a new position worth an estimated $14.1M. The largest seller was Millennium Management, exiting entirely with an estimated $18M sold.
- 130 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q2 2018, down from 134 in Q1 2018.
- Funds reported $973M of Flexion Therapeutics, Inc. stock for Q2 2018, up 18% quarter-over-quarter.
- 16 funds opened new Flexion Therapeutics, Inc. positions in Q2 2018 and 20 closed out, a net change of -4 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q2 2018 was Artisan Partners, an estimated $14.1M added.
- The largest Flexion Therapeutics, Inc. seller in Q2 2018 was Millennium Management, an estimated $18M sold.
Based on aggregated 13F filings for Q2 2018.